Borski Fund

Amsterdam, Netherlands
Venture Capital
Active
Total investments

18

Average round size

4M

Portfolio companies

16

Lead investments

5

Follow on index

0.11

Areas of investment
E-CommerceSoftwareSalesFitnessHealth CareManufacturingMedical DeviceFashionImage RecognitionNanotechnology

Investor highlights

Stage focus
Seed
Geo focus
Netherlands

Preferences and restrictions

Requirements for founders
Female

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 21000000
Fund raised date
2019-11-18

Analytics

Total investments
18
Lead investments
5
Follow on index
0.11
Investments by industry
  • Health Care (7)
  • Software (5)
  • E-Commerce (4)
  • Medical Device (3)
  • Manufacturing (3)
  • Show 24 more
Investments by region
  • The Netherlands (8)
  • Netherlands (5)
  • Germany (2)
  • United States (1)
  • Ireland (1)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Group Appearance index
0.83

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
DUDE CHEM07 Feb 2024Manufacturing, Pharmaceutical, ChemicalSeed7MBerlin, Berlin, Germany
Ziel01 Jul 2020E-Commerce, Sales, Fitness, Marketing, FashionEarly Stage Venture4MUnited States, New York, New York
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.